
Corcept Therapeutics Incorporated CORT
€ 34.37
2.78%
Quartalsbericht 2025-Q3
hinzugefügt 04.11.2025
Corcept Therapeutics Incorporated Langfristiger Schuldenstrom 2011-2026 | CORT
Langfristiger Schuldenstrom Jährlich Corcept Therapeutics Incorporated
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 829 K | 151 K | 1.14 M | 526 K | 2.05 M | 1.56 M | - | - | 14.7 M | 15 M | 9.42 M | 5.74 M | 2.65 M | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 15 M | 151 K | 4.88 M |
Langfristiger Schuldenstrom anderer Aktien in der Pharmaeinzelhändler
| Name | Langfristiger Schuldenstrom | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
3.63 M | - | 2.43 % | $ 254 M | ||
|
ARCA biopharma
ABIO
|
213 K | - | 1052.0 % | $ 415 M | ||
|
Adaptive Biotechnologies Corporation
ADPT
|
10.2 M | $ 18.38 | -0.68 % | $ 2.7 B | ||
|
Amgen
AMGN
|
107 M | $ 344.65 | 0.81 % | $ 185 B | ||
|
Arrowhead Pharmaceuticals
ARWR
|
7.29 M | $ 71.99 | 3.84 % | $ 9.63 B | ||
|
Biogen
BIIB
|
86.4 M | $ 178.18 | -0.95 % | $ 25.9 B | ||
|
I-Mab
IMAB
|
8.06 M | - | - | $ 866 M | ||
|
Aytu BioScience
AYTU
|
137 K | $ 2.65 | 1.92 % | $ 16.6 M | ||
|
Adagene
ADAG
|
1.18 M | $ 2.96 | 7.64 % | $ 167 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
43 K | $ 4.16 | 3.74 % | $ 9.05 B | ||
|
Alterity Therapeutics Limited
ATHE
|
57.6 K | $ 3.18 | 0.32 % | $ 7.65 B | ||
|
Acorda Therapeutics
ACOR
|
1.59 M | - | -24.86 % | $ 820 K | ||
|
Compugen Ltd.
CGEN
|
768 K | $ 1.86 | 1.1 % | $ 167 M | ||
|
Aptose Biosciences
APTO
|
428 K | - | -45.71 % | $ 1.2 M | ||
|
Acasti Pharma
ACST
|
75 K | - | 4.01 % | $ 150 M | ||
|
Celldex Therapeutics
CLDX
|
1.45 M | $ 24.86 | 1.06 % | $ 1.6 M | ||
|
Cellectis S.A.
CLLS
|
8.38 M | $ 3.87 | 2.22 % | $ 116 M | ||
|
Aeglea BioTherapeutics
AGLE
|
625 K | - | - | $ 1.01 B | ||
|
Akebia Therapeutics
AKBA
|
4.49 M | $ 1.41 | - | $ 264 M | ||
|
Albireo Pharma
ALBO
|
3.08 M | - | -0.23 % | $ 916 M | ||
|
Allena Pharmaceuticals
ALNA
|
317 K | - | 3.16 % | $ 1.9 M | ||
|
Ascendis Pharma A/S
ASND
|
14.2 M | $ 224.87 | -0.54 % | $ 5 B | ||
|
Ampio Pharmaceuticals
AMPE
|
274 K | - | -11.43 % | $ 502 K | ||
|
Applied Molecular Transport
AMTI
|
4.64 M | - | - | $ 10.1 M | ||
|
Aravive
ARAV
|
2.2 M | - | -13.39 % | $ 1.45 M | ||
|
BioNTech SE
BNTX
|
39.5 M | $ 110.01 | -3.29 % | $ 27.2 B | ||
|
Athira Pharma
ATHA
|
414 K | - | - | $ 269 M | ||
|
Aeterna Zentaris
AEZS
|
271 K | - | 5.93 % | $ 314 M | ||
|
Autolus Therapeutics plc
AUTL
|
5.05 M | $ 1.39 | 1.5 % | $ 355 M | ||
|
AgeX Therapeutics
AGE
|
428 K | - | -10.17 % | $ 12.2 K | ||
|
AVROBIO
AVRO
|
878 K | - | 1083.1 % | $ 745 M | ||
|
Cardiff Oncology
CRDF
|
710 K | $ 1.73 | -1.43 % | $ 82.4 M | ||
|
Akouos
AKUS
|
671 K | - | 0.23 % | $ 488 M | ||
|
Adaptimmune Therapeutics plc
ADAP
|
5.38 M | - | -15.15 % | $ 60.3 M | ||
|
DBV Technologies S.A.
DBVT
|
654 K | $ 21.75 | 0.65 % | $ 2.11 B | ||
|
Brickell Biotech
BBI
|
49 K | - | -5.38 % | $ 6.06 M | ||
|
Amneal Pharmaceuticals
AMRX
|
224 M | $ 14.25 | 4.13 % | $ 4.4 B | ||
|
AIkido Pharma
AIKI
|
410 K | - | 1.93 % | $ 17.4 M | ||
|
Atreca
BCEL
|
3.54 M | - | -11.76 % | $ 5.79 M | ||
|
CureVac N.V.
CVAC
|
3.47 M | - | - | $ 867 M | ||
|
Acer Therapeutics
ACER
|
104 K | - | 2.71 % | $ 14 M | ||
|
BioCryst Pharmaceuticals
BCRX
|
937 K | $ 6.72 | 2.05 % | $ 1.39 B |